RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
@cristian_anez , @OctavioAparic13, @SanHolo24706738 , @DiegoMa26743024 @MinSaludBolivia
RT @robertpdickson: Does any actual data exist to support this improbable hypothesis (that immunosuppressed patients are protected from COV…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @robertpdickson: Does any actual data exist to support this improbable hypothesis (that immunosuppressed patients are protected from COV…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Does any actual data exist to support this improbable hypothesis (that immunosuppressed patients are protected from COVID)? "Blunt the immunity of patients with severe viral infections" should be met with skepticism, IMO. Instead it's being widely embrac
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/UTMpInTkTK
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Great review by @LancetRespirMed on #COVID19 & some valuable guidance
Great review by @TheLancet on #COVID19
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @paomorejon: 🏥 Up to 12% of all positive cases required ICU admission Complications: •ARDS: 60–70% •Shock: 30% •Myocardial dysfunction:…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @LancetMicrobe: New @LancetRespirMed review> Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommenda…
RT @StephenLap: Superb overview of all aspects of #COVID19 ICU management from Singapore (by @ccmtoronto alumnus): https://t.co/tFodG4FgNC
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @StephenLap: Superb overview of all aspects of #COVID19 ICU management from Singapore (by @ccmtoronto alumnus): https://t.co/tFodG4FgNC
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
Superb overview of all aspects of #COVID19 ICU management from Singapore (by @ccmtoronto alumnus): https://t.co/tFodG4FgNC
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
Cool
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
Intensive care management of coronavirus disease 2019 (#COVID-19): challenges and recommendations Phua et al, 6 April 2020 https://t.co/4G5e9vZRfC
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/a4l0M9BUsW via @LancetRespirMed
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
《重要》 コロナウイルス病(COVID-19)のICU管理における課題と推奨事項 Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respiratory Medicine https://t.co/Mygj54omRb
#AyudaBiblioteca En UCI ¿Se deben administrar bloqueadores de citoquinas para prevenir la neumonía o la descompensación? https://t.co/I5MdI4lUfL
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t.co/cqXd5RMWzx on new Review of #intensivecare management https://t.co/5brvKsevMa https://t.co/xVYo2FtzBs
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Mag hopen dat @rivm deze keer wel de medische vakliteratuur bijhoudt.
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: “No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investiga…